Abstract:Purpose/Objective(s) Mouse models of HNC have played an essential role in elucidating mechanisms driving tumor development and progression. However, the generation of new mouse models are extremely costly, laborious and time consuming, and are limited to the study of a few, and often “popular,” gene targets that do not fully recapitulate the intertumoral heterogeneity of HNCs. Using a novel preclinical model developed in our lab that involves the in vivo introduction of human-relevant HNC mutations by CRISPR-mediated gene editing, we aim to functionally interrogate and reveal molecular pathways and mechanisms driving tumor initiation and progression, and to test the highly intriguing, but as yet unproven, hypothesis that HNC initiation is driven by the acquisition and accumulation of mutations in somatic tissue stem cells and their progeny, a process of mutagenesis that may be influenced by sex and accelerated following carcinogen exposure. Materials/Methods Our data shows effective AAV transduction and targeted mutagenesis of multiple stem cell lineages (epithelial stem cells, mesenchymal stromal cells, and muscle stem cells) by numerous AAV serotypes after local AAV injection into the tongue, oral epithelium, pharynx/esophagus, and neck. Delivery of a custom AAV-CRISPR-library (10 sgRNAs/gene), targeting the 20 most frequently mutated genes in human HNCs, into male and female mice (n=32) conditionally expressing Cas9 in a lineage-selective manner, produced morphologically and anatomically distinct tumors that recapitulate the genetic heterogeneity and sex-variant emergence of human HNCs. Results Individual tumors show distinct combinations of missense (M), nonsense (N) and silent mutations in targeted genes that also are mutated in human HNCs (sample type [tumor vs PAT]: p<0.0001; mutation type [missense vs nonsense vs silent]: p<0.0001; anatomic location: p<0.0001) Molecular sequencing analysis from AAV-CRISPR-HNC tumors (n=29) reveal striking genetic diversity and high mutational burden that is reminiscent of human HNCs. Sequencing analysis from paired adjacent tissue (PAT; n=29) provides evidence of an intermediate precancerous state and field cancerization and points to a subset of the genetic targets in our custom library as particularly consequential for stem cell transformation in this model (gene, p<0.001; mutation type, p<0.001; anatomic location, p<0.001). Frameshift insertions/ deletions accounted for the majority of INDELS observed (>50%; p<0.0001), and further supports the use of our platform to introduce loss of function mutations in HNC tumors. Conclusion Taken together, our data suggests for the first time that somatic stem cells can serve as cells-of-origin for multiple, different HNC subtypes, and that HNCs may represent clonal diseases. Future applications of this innovative and translationally-oriented system will help to nominate new therapeutic targets and create a springboard for efforts to prevent and treat HNC.

The Fetal Mouse is a Sensitive Genotoxicity Model That Exposes Lentiviral-associated Mutagenesis Resulting in Liver Oncogenesis

Assessment of Pre-Clinical Liver Models Based on Their Ability to Predict the Liver-Tropism of Adeno-Associated Virus Vectors

In Vivo Biosafety Model to Assess the Risk of Adverse Events from Retroviral and Lentiviral Vectors.

Analysis of hepatic lentiviral vector transduction; implications for preclinical studies and clinical gene therapy protocols

Analysis of hepatic lentiviral vector transduction; implications on preclinical studies and clinical gene therapy protocols.

206. Frequency and Analysis of Liver Tumors in AAV-Treated B6C3F1 Hybrid Mice

Functional Assessment of Expression of Cre Recombinase Targeting the Liver of Transgenic Mice Regulated by Tet-on and Cre/loxP System

A humanized mouse model for adeno-associated viral gene therapy

Using the BLT Humanized Mouse As a Stem Cell Based Gene Therapy Tumor Model

A Novel Immunocompetent Preclinical Mouse Model to Uncover Oncogenic Initiators of Head and Neck Cancer

Genomic Designs of Raavs Contribute to Pathological Changes in the Livers and Spleens of Mice

Analysis of Tumors Arising in Male B6c3f1 Mice with and Without Aav Vector Delivery to Liver

Discovering human cell‐compatible gene therapy virus variants via optimized screening in mouse models

Teratogenic Toxicity Evaluation of Bladder Cancer-Specific Oncolytic Adenovirus on Mice.

Expression of Hepatitis C Virus Non-Structural 5a Protein in the Liver of Transgenic Mice

AAV Capsid Screening for Translational Pig Research Using a Mouse Xenograft Liver Model

Aberrant transcription and post-transcriptional processing of hepatitis C virus non-structural genes in transgenic mice

Development of pre-clinical murine models for fibrolamellar hepatocellular carcinoma

Vascular defects and liver damage by the acute inactivation of the VHL gene during mouse embryogenesis

Characterisation of Liver Pathogenesis, Human Immune Responses and Drug Testing in a Humanised Mouse Model of HCV Infection

Human Cytomegalovirus-IE2 Affects Embryonic Liver Development and Survival in Transgenic Mouse